StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) stock

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.35−0.05 (-3.54%)

Close on Nov 17, 2026Market cap $2.95MP/E –Yield –

GRI Bio total assets

Total assets on the balance sheet at the end of each period.

GRI Bio's total assets was $11.38M at Jun 30, 2026. For fiscal 2025 it was $8.67M, up 51.0% from the year before. The highest annual figure on record is $8.67M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.67M+51.0%
FY2024Dec 31, 2024$5.74M+94.1%
FY2023Dec 31, 2023$2.96M+671.8%
FY2022Dec 31, 2022$383.00K-95.4%
FY2021Dec 31, 2021$8.34M+772.8%
FY2020Dec 31, 2020$955.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.38M+100.5%
Q1 FY2026Mar 31, 2026$11.34M+180.5%
Q4 FY2025Dec 31, 2025$8.67M+51.0%
Q3 FY2025Sep 30, 2025$4.78M-12.4%
Q2 FY2025Jun 30, 2025$5.68M-19.3%
Q1 FY2025Mar 31, 2025$4.04M-11.9%
Q4 FY2024Dec 31, 2024$5.74M+94.1%
Q3 FY2024Sep 30, 2024$5.46M+24.0%
Q2 FY2024Jun 30, 2024$7.03M+24.6%
Q1 FY2024Mar 31, 2024$4.59M+118.7%
Q4 FY2023Dec 31, 2023$2.96M+671.8%
Q3 FY2023Sep 30, 2023$4.40M-20.9%
Q2 FY2023Jun 30, 2023$5.64M-29.5%
Q1 FY2023Mar 31, 2023$2.10M-64.7%
Q4 FY2022Dec 31, 2022$383.00K-95.4%
Q3 FY2022Sep 30, 2022$5.57M-45.1%
Q2 FY2022Jun 30, 2022$8.01M-31.3%
Q1 FY2022Mar 31, 2022$5.94M-59.3%
Q4 FY2021Dec 31, 2021$8.34M+772.8%
Q3 FY2021Sep 30, 2021$10.14M–
Q2 FY2021Jun 30, 2021$11.65M–
Q1 FY2021Mar 31, 2021$14.60M–
Q4 FY2020Dec 31, 2020$955.00K–

More GRI Bio figures

See a number that looks wrong?